
Please try another search
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP, an online platform to pick winners among candidate molecules for CESS powered nanoforming. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Name | Age | Since | Title |
---|---|---|---|
Albert Alexander Haeggström | 50 | 2015 | CFO & Director |
Cynthia Schwalm | 61 | 2020 | Director |
Jeanne A. Thoma | 62 | 2021 | Independent Director |
Mads Laustsen | 65 | 2019 | Independent Vice Chairman of the Board |
Miguel Maria Calado | 67 | 2019 | Independent Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review